44 participants
Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-22
- Start Date:
- 2017-10-24
- Completion:
- 2021-09-30
Conditions
- Relapsed or Refractory Haematological Malignancies Including
- Acute Myeloid Leukemia
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- High Risk Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
- Richter's Syndrome
- B-cell Non-Hodgkin Lymphoma
- T-cell Non-Hodgkin Lymphoma
- Small Lymphocytic Lymphoma
- Multiple Myeloma
Interventions
- DRUG
No Results Yet